Chief Commercial Officer
Jolian has over 20 years’ experience in the animal health sector with several leading companies including MSD, Zoetis, Pfizer, Novartis and Leo in a variety of commercial positions both in the UK and the EU.
Jolian began his career in animal health as a sales representative, then moved into marketing to manage the Rimadyl (Carprofen) brand. Following the creation of a central European function at Pfizer, Jolian relocated to Paris to take on the newly created role of European Brand Team Leader, launching both Cerenia and Trocoxil across the EU region.
Since 2007 he has led teams at a European level and been a member of the European Business Unit leadership team. This involved working in a variety of European marketing and strategic planning positions across multiple species sectors, to bring new medicines from clinical trial development to a pre-launch, and subsequently to full commercial launch. In 2010 he led the integration process between the Pfizer and Fort Dodge equine business units. This involved supporting local countries to develop operational teams and establish a business unit portfolio through new product development, phase IV planning, geographic expansion and licensing.
Following a return to the UK in 2013, Jolian led the marketing and technical team that oversaw the launch of Bravecto, a novel innovation in the ectoparasiticide sector. To further broaden his healthcare experience, he entered the human health dental sector with Simplyhealth leading the marketing team for Denplan.
Carus focuses on developing an innovation led portfolio and novel life science technology platforms for application in the animal health sector. Jolian is looking forward to shaping this strategy and partnering with organisations to achieve these goals.